Skip to main content

Advertisement

SpringerLink
Log in

Management of cancer pain

  • Symposium: Managing of Complications in Patients with Cancer
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

In the last decades, studies validating the WHO analgesic ladder have been shown to have methodological limitations and different problems are unresolved due to a lack of controlled studies on this subject. These problems include a better definition of the role of NSAIDs, the prolonged use of NSAIDs in cancer pain, and the utility of step 2. Moreover, the indications for using different strong opioids and alternate routes of administration to improve pain relief in difficult pain situations are not well established. The proportion of patients who do not benefit from these treatments remain unclear, and how the opioid response may be improved with the use of adjuvants is also uncertain. This review will offer an update on these problems and the existing therapeutic opportunities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benitez-Rosario M, Salinas-Martin A, Aguirre-Jaime A, Perez-Mendez L, Feria M (2009) Morphine–methadone opioid rotation in cancer patients: analysis of dose predicting factors. J Pain Symptom Manage 37:1061–1068

    Article  CAS  PubMed  Google Scholar 

  2. Caraceni A, Zecca E, Bonezzi C et al (2004) Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22:2909–2917

    Article  CAS  PubMed  Google Scholar 

  3. Cleeland CS, Gonin R, Hatfield AK et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592–596

    Article  CAS  PubMed  Google Scholar 

  4. Cherny NJ, Chang V, Frager G et al (1995) Opioid pharmacotherapy in the management of cancer pain. Cancer 76:1288–1293

    Google Scholar 

  5. Cherny N, Ripamonti C, Pereira J et al (2001) Expert Working Group of the European Association of Palliative Care Network Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19:2542–2554

    CAS  PubMed  Google Scholar 

  6. De Conno F, Ripamonti C, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, Arcuri E, Bertetto O, MERITO Study Group (2008) The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain. Palliat Med 22:214–221

    Article  PubMed  Google Scholar 

  7. Eisenberg E, Berkey C, Carr DB, Mosteller F, Chalmers C (1994) Efficacy and safety of non steroidal antinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 12:2756–2765

    CAS  PubMed  Google Scholar 

  8. Grape S, Schug SA, Lauer S, Schug BS (2010) Formulations of fentanyl for the management of pain. Drugs 70:57–72

    Article  CAS  PubMed  Google Scholar 

  9. Grond S, Radbruch L, Meuser T et al (1999) High-dose tramadol in comparison to low-dose morphine for cance`r pain relief. J Pain Symptom Manage 18:174–179

    Article  CAS  PubMed  Google Scholar 

  10. Hanks GW, De Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593

    Article  CAS  PubMed  Google Scholar 

  11. Jadad AR, Browman GP (1995) The WHO analgesic ladder for cancer pain management. JAMA 274:1870–1873

    Article  CAS  PubMed  Google Scholar 

  12. Marinangeli F, Ciccozzi A, Leonardis M et al (2004) Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 27:409–416

    Article  CAS  PubMed  Google Scholar 

  13. McNicol E, Strassels S, Goudas L, Lau J, Carr D (2004) Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review. J Clin Oncol 22:1975–1992

    Article  CAS  PubMed  Google Scholar 

  14. Mercadante S, Salvaggio L, Dardanoni G, Agnello A, Garofalo S (1998) Dextropropoxyphene versus morphine in opioid-naïve cancer patients with pain. J Pain Symptom Manage 15:76–81

    Article  CAS  PubMed  Google Scholar 

  15. Mercadante S (1999) Pain treatment and outcome in advanced cancer patients followed at home. Cancer 85:1849–1858

    Article  CAS  PubMed  Google Scholar 

  16. Mercadante S (1999) Opioid rotation in cancer pain rationale and clinical aspects. Cancer 86:1856–1866

    Article  CAS  PubMed  Google Scholar 

  17. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A (2002) Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori 88:239–242

    CAS  PubMed  Google Scholar 

  18. Mercadante S, Fulfaro F, Casuccio A (2002) A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer on morphine therapy: effect on dose-escalation and pharmacoeconomic analysis. Eur J Cancer 38:1358–1363

    Article  CAS  PubMed  Google Scholar 

  19. Mercadante S, Porzio G, Ferrera P et al (2006) Low morphine dose in opioid-naïve cancer patients with pain. J Pain Symptom Manage 31:242–247

    Article  CAS  PubMed  Google Scholar 

  20. Mercadante S, Bruera E (2006) Opioid switching: a systematic and critical review. Cancer Treat Rev 32:304–315

    Article  CAS  PubMed  Google Scholar 

  21. Mercadante S, Porzio G, Ferrera P et al (2008) Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 12:1040–1046

    Article  CAS  PubMed  Google Scholar 

  22. Mercadante S (2007) Opioid titration in cancer pain: a critical review. Eur J Pain 11:823–830

    Article  CAS  PubMed  Google Scholar 

  23. Mercadante S, Ferrera P, Villari P et al (2009) Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 37:632–641

    Article  PubMed  Google Scholar 

  24. Mystakidou K, Tsilika E, Kouloulias V et al (2003) Long-term cancer pain management in morphine pre-treated and opioid naïve patients with transdermal fentanyl. Int J Cancer 107:486–492

    Article  CAS  PubMed  Google Scholar 

  25. Mystakidou K (2004) Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II & III transfers. J Pain 5:119–132

    Article  CAS  PubMed  Google Scholar 

  26. Portenoy RK, Hagen NA (1990) Breakthrough pain: definition, prevalence, and characteristics. Pain 41:273–281

    Article  CAS  PubMed  Google Scholar 

  27. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:850–856

    Article  CAS  PubMed  Google Scholar 

  28. Vielvoye-Kerlmeer A, Mattern C, Uitendaal M (2000) Transdermal fentanyl in opioid-naïve cancer patients: an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naïve patients and a group using codeine. J Pain Symptom Manage 19:185–192

    Article  Google Scholar 

  29. World Health Organization (1990) Cancer pain relief and palliative care. WHO, Geneva

    Google Scholar 

  30. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63:65–76

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Anesthesia and Intensive Care Unit, Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Via San Lorenzo 312, 90146, Palermo, Italy

    Sebastiano Mercadante

Authors
  1. Sebastiano Mercadante
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastiano Mercadante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercadante, S. Management of cancer pain. Intern Emerg Med 5 (Suppl 1), 31–35 (2010). https://doi.org/10.1007/s11739-010-0448-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-010-0448-8

Keywords

Search

Navigation